Cargando…
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018
BACKGROUND: Patients infected with the novel coronavirus (SARS-CoV-2) are being treated empirically with oseltamivir, but there is little evidence from randomised controlled trials to support the treatment of coronavirus infections with oseltamivir. AIM: To determine whether adding oseltamivir to us...
Autores principales: | Coenen, Samuel, van der Velden, Alike W, Cianci, Daniela, Goossens, Herman, Bongard, Emily, Saville, Benjamin R, Gobat, Nina, de Paor, Muireann, Ieven, Margareta, Verheij, Theo J, Butler, Christopher C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311109/ https://www.ncbi.nlm.nih.gov/pubmed/32571773 http://dx.doi.org/10.3399/bjgp20X711941 |
Ejemplares similares
-
Oseltamivir bij infectie door een humaan coronavirus: Post-hocanalyse van gegevens uit 2016-2018
por: van der Velden, Alike, et al.
Publicado: (2020) -
Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
por: Verheij, Theo J, et al.
Publicado: (2022) -
A trial like ALIC(4)E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
por: Butler, Christopher C., et al.
Publicado: (2018) -
Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course
por: Bruyndonckx, Robin, et al.
Publicado: (2020) -
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC(4) E): the ALIC(4) E protocol
por: Bongard, Emily, et al.
Publicado: (2018)